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Abstract
Background: This paper describes the experiences of Australian general practitioners (GPs) in managing
problematic crystal methamphetamine (crystal meth) use among two groups of male patients: gay men and
HIV positive men.
Methods: Semi-structured qualitative interviews with GPs with HIV medication prescribing rights were
conducted in Sydney, Adelaide and a rural-coastal town in New South Wales between August and
October 2006. Participants were recruited from practices with high caseloads of gay and HIV positive men.
Results: Sixteen GPs were recruited from seven practices to take part in interviews. Participants included
14 male GPs and two female GPs, and the number of years each had been working in HIV medicine ranged
from two to 24. Eleven of the GPs who were based in Sydney raised the issue of problematic crystal meth
use in these two patient populations. Five key themes were identified: an increasing problem; associations
with depression; treatment challenges; health services and health care; workforce issues.
Conclusion: Despite study limitations, key implications can be identified. Health practitioners may benefit
from broadening their understandings of how to anticipate and respond to problematic levels of crystal
meth use in their patients. Early intervention can mitigate the impact of crystal meth use on co-morbid
mental illness and other health issues. Management of the complex relationships between drug use,
depression, sexuality and HIV can be addressed following a 'stepped care' approach. General practice
guidelines for the management of crystal meth use problems should address specific issues associated with
gay men and HIV positive men. GPs and other health practitioners must appreciate drug use as a social
practice in order to build trust with gay men to encourage full disclosure of drug use. Education programs
should train health practitioners in these issues, and increased resourcing provided to support the often
difficult task of caring for people who use crystal meth. Greater resourcing of acute care and referral
services can shift the burden away from primary care and community services. Further investigation should
consider whether these findings are reproducible in other general practice settings, the relationship
between depression, drug use and HIV medication, and challenges facing the HIV general practice
workforce in Australia.
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Background
The chemist and pharmacologist Fritz Hauschild devel-
oped the sympathomimetic agent Pervitin (metampheta-
min) in the 1930s [1]. Methamphetamine, a derivative of
amphetamine, was widely prescribed in the 1950s and
1960s as a medication for depression and obesity, reach-
ing a peak of 31 million prescriptions in the United States
in 1967 [2]. Now widely available in many nations as a
street drug in either base, powder or crystalline ('crystal
meth' or 'ice') forms, this central nervous system stimu-
lant can be injected or ingested nasally or orally. The most
frequently reported positive effects are feeling more awake
or alert, increased energy and sociability, and aphrodisiac
qualities, while negative effects reported by users include
'comedown', paranoia and inability to sleep [3]. A study
of regular methamphetamine users in Sydney found that
most preferred base and ice because they 'provided a more
intense and longer lasting high' [4].
In a poignant reversal of the original application of meth-
amphetamine as an antidepressant treatment, rates of
depression diagnosis and prescription of antidepressants
are significantly higher among Sydney methamphetamine
users than the general population [4]. While there is little
evidence that depressed people are more likely to use crys-
tal meth [5], dependence on and recent use of crystal meth
has been associated with reported symptoms of depres-
sion in multiple studies [eg. [6]]. Methamphetamine
withdrawal symptoms, including fatigue, anhedonia,
depressed mood, paranoia and hypersomnia, are com-
mon to depression and are often severe enough to precip-
itate relapse [5]. These effects are reported to be more
severe with crystal meth than other forms of methamphet-
amine [4].
The behavioural data indicate that crystal meth is becom-
ing an increasingly normative part of the Australian gay
scene, associated mostly with dance parties but also with
sexual activity in other settings for some users [3]. Impor-
tantly, the research indicates that most of the gay men
who use crystal meth regularly manage this use with few
problems [7]. However, there is still a considerable
minority of men who report dependent levels of crystal
meth use [7]. Just over 20% of gay men participating in
the 2007 Sydney Gay Community Periodic Survey
reported using crystal meth in the previous six months [8].
This had increased significantly from around 12% in
2002. Amongst those who used crystal meth in the six
months prior to the 2007 survey, nearly half used it at
least monthly [8]. In people living with HIV/AIDS (of
which the great majority in Australia are gay men [9]),
depression has been shown to be associated with a history
of illicit drug use [10], and other studies have suggested
that co-morbid depression and drug use are associated
with decreased HIV treatment uptake, treatment adher-
ence problems and virological suppression [11]. In sum,
this literature suggests that while some gay men and some
HIV positive men may be able to integrate occasional crys-
tal meth use into their lives with minimal impact, others
are using to a degree that can have problematic conse-
quences for health as well as social and economic wellbe-
ing.
This paper explores how reported instances of problem-
atic crystal meth use among gay men and HIV positive
men are affecting the work of general practitioners (GPs)
in Australia. Although there has been growing concern in
gay communities about rates of crystal meth use [12], we
believe this to be the first analysis of the experiences of
Australian GPs who work with gay men and HIV positive
men who use crystal meth.
Methods
The data reported in this paper are drawn from the Pri-
mary Health Care Project on HIV and Depression, an
interdisciplinary and multi-method study exploring the
complex relationships between sexuality, HIV and depres-
sion. Written informed consent was obtained from all par-
ticipants. Ethics approval was granted by the National
Research and Evaluation Ethics Committee of the Royal
Australian College of General Practitioners (Approval No:
RACGP NREEC 05/35) and the Human Research Ethics
Committees of The University of New South Wales and
The University of Adelaide.
The study methodology has been described elsewhere
[13,14], but there are several aspects that are important to
report in relation to this paper. First, this paper is focused
on data gathered in the first of three stages of the project.
This stage comprised semi-structured interviews with s100
HIV prescriber GPs, eg. primary care physicians trained
and accredited to prescribe HIV medication. Sixteen inter-
views were conducted with GPs (14 male, 2 female) who
were based in three Australian cities: two state capitals,
one large (Sydney) and one small (Adelaide); and one
rural-coastal city. The seven practices in which the GPs
were based each treated a high caseload of the gay or
homosexually active men and HIV positive men that lived
in those areas.
The second important aspect of the method is that this
paper is focused on the experiences reported by the eleven
GPs who were based in Sydney, each of whom raised the
issue of problematic patient crystal meth use during the
interviews. A semi-structured interview format was
employed in the interviews to allow for consistency as
well as flexibility in remaining responsive to the range of
issues and ideas that can emerge in an open-ended con-
versation. Following the aims of the study, GPs were asked
to focus on their experiences as they related to the treat-BMC Family Practice 2008, 9:45 http://www.biomedcentral.com/1471-2296/9/45
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ment of gay men and HIV positive men. However, there
was minimal guidance in terms of what the GPs may or
may not find most topical or challenging about those
experiences. A thematic analysis of deidentified tran-
scripts was applied using NVivo 7 [15] and following the
principles of open and axial coding [16]. Reliability was
established through a process of independent coding and
discussion amongst the research team. This process iden-
tified key themes on: how gender and sexuality differen-
tially shaped the experience of depression in gay men in
comparison with heterosexual men [13]; how a long term
and trusting relationship between doctor and patient
increased the likelihood of a timely diagnosis of depres-
sion in HIV positive men [17]; and how the growing range
of clinical and contextual challenges for GPs working in
HIV affected their capacity to manage depressive illness in
both gay men and in HIV positive men.
The issue of patient crystal meth use was only raised in the
eleven interviews conducted with Sydney-based GPs.
These eleven GPs represent more than one third of all of
the s100 HIV prescriber GPs working in the inner suburbs
of Sydney [18]. The rest of this paper will explore five key
themes in the reported experiences of these eleven GPs,
focusing on their observations of problematic crystal
meth use in gay men and in HIV positive men in Sydney.
It is important to note that GPs often spoke about these
two patient populations interchangeably. Where a distinc-
tion was clear this has been reported as such, however, the
more common conflation or substitution of their identi-
fying features is discussed in the final section of the paper.
Results
Increasing problem
The first and most common theme in the reported experi-
ences of GPs is that crystal meth use has dramatically
increased in recent years among the populations of gay
men and HIV positive men they treat in Sydney:
I mean recreational drugs have always been around,
but not to the extent where people are not complying
with their medication so much and getting depressed,
and getting physically and mentally ill with things like
crystal meth ... I mean I've been away and then this last
year this seems to be an ongoing problem that people
are ... trying to deal with. [GP3]
An important characteristic of this theme is that not only
is crystal meth use growing, but that problematic levels of
crystal meth use are being observed in gay men and posi-
tive men who do not have a history of problematic levels
of drug use:
I'm really surprised at the level of crystal use out
there.... And the folk who I would least expect to actu-
ally access it, because it's so freely available, and part
of the party scene now, who are now accessing and
who are now using. And have been actually now shall
we say 'hooked in', and are now becoming regular
users. And I've been quite surprised at who's actually
taking this up. Now these are folk that I would assume
would have some degree of control over their actions...
I'm talking about men in their thirties and forties who
have been around, who know the scene, but who are
now actively involved in crystal use ... I'm, it really
worries me the extent of addiction that's actually hap-
pening, about people I would least expect. [GP7]
Associations with depression
A second theme focuses on the observed associations
between problematic levels of crystal meth use and
depression in both gay men and in HIV positive men:
In terms of depression at the moment, one of our
major problems in this environment at the moment
would be the crystal 'epidemic', or whatever you want
to call it. And that can make a lot of people very
depressed! [GP4]
But I would say, amphetamine use is pretty high and
linked with this depression, particularly linked with
depression. [GP10]
However, this association is not seen as simple or straight-
forward; rather, the associations between depression and
crystal meth use are represented as quite complex and dif-
ficult to tease apart:
I mean most boys using large amounts of crystal are
depressed. And how you address that in the context of
perhaps ongoing crystal use and work out what's
depression as such or what's a drug effect, or why
someone's using crystal, I think that's a major problem
we're dealing with at the moment. [GP4]
Well, why are people [having] drug and alcohol issues
in the first place? Is it because there is a pre existing
depression and this is actually part of trying to mask
that? It's drawing a long bow to say that will, going
[down] that path, cause a depression. Is there a pre
existing depression here anyway? [GP7]
Treatment challenges
A third theme describes the various ways in which crystal
meth use creates treatment challenges for GPs, including
in the effective clinical management of depression:
If someone's injecting a lot of amphetamines, it's very
hard to diagnose depression. Also medication's prob-
ably not going to be particularly useful. [GP6]BMC Family Practice 2008, 9:45 http://www.biomedcentral.com/1471-2296/9/45
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Post party depression. It's very common, and then a
few days later they're fine. When people are withdraw-
ing from substances, I've seen people get diagnosed,
put on major, major tranquillisers and antidepres-
sants. And I don't, I'm not sure if they really needed it.
[GP9]
There's a lot of substance abuse that negates antide-
pressant therapy, things like that. I mean, [antidepres-
sant drug] isn't going to do much good if people are
doing crystal meth every weekend, do you know what
I mean? ... And the patients don't necessarily tell you
that they have these problems, or that they are using
these things. It's very common to see. Gay men come
in here and say, "I'm depressed and I really want to do
something about it. I've heard about antidepressant
medication. I want to go on it." And they don't tell
you, even if you ask them specifically, that they are
using stimulants recreationally, until some time later.
Yeah, that's a big obstacle. [GP5]
Treatment challenges are further complicated when con-
sidering the clinical management of HIV alongside co-
morbid depression and drug use:
However, with the advent of our HIV population, with
the use of, particularly the use of ice, particularly the
use of crystal... I have actually seen stable people who
I thought were quite well controlled on their, either
their cognitive behavioural therapy or their antide-
pressant medication, talk to me about suicidal intent
coming down off their crystal. And that's creating
some problems for me at the moment. [GP7]
Positive men and depression? No, it's this whole sort
of soup of depression, self esteem, drug use. Trying to
tease them out and treat. So I think you really need to
make sure you're treating all of them. [GP11]
Health services and health care
A fourth theme focuses on the capacity of health services
to provide effective care for gay men and HIV positive
men who are experiencing problematic levels of crystal
meth use, particularly in terms of their mental health care
needs:
There needs to really urgently, urgently address the
drug issue. People who become acutely depressed or
psychotic or both, under the influence of drugs. And
rehabilitation for it. Because generally they're just sent
out of hospital. They ring you up and go, "They've just
been discharged. Filled them up with tranquillisers
and discharged them on Monday morning". And
there's no follow up, there's nothing ... And then the
person doesn't come back, like I can't get hold of
them. So I don't, I think there has to be a better system
in place so that these people don't cause social harm
by going berserk in the community as well ... And to
get someone into a private psychiatrist interested in
drug and alcohol can take months. And that, even
costlier are those private rehab places. [GP9]
Related to health service capacity are the attitudes of
health practitioners, including the observed reluctance of
some referral specialists to accept clients who use crystal
meth:
And I won't name names, but I send to, a lot of these
people, to a certain psychiatrist. And he said, "Don't
send me any more!" [laughs] Because he's fed up with
them. And I would be too, I guess. [GP9]
GPs commonly stressed the importance of providing non-
judgmental support to men who were using crystal meth,
whether or not they felt it was a problematic behaviour.
This aspect of the theme implies that effective health care
requires the absence of both social prejudice and criminal
implications:
Because most people would come to us for a sexual
health reason in the beginning and like the atmos-
phere or like the doctors, or whatever. Most of them
liked the non judgemental ... And being in the city,
they liked being able to say that they were feeling a bit
tired but could it have been the five trips and crystal
they had on the weekend. And we didn't ring the
police and fall off our chairs. So they'd come back with
an earache. [GP8]
Workforce issues
The final theme describes some key issues facing the GP
workforce members who provide care to these popula-
tions of gay men and HIV positive men in inner city Syd-
ney. This includes GPs feeling unprepared to support the
number of men seeking treatment for crystal meth addic-
tion and associated co-morbidities:
And I'm seeing people I'd least expect saying to me, "I
can't stand this. I've just got to get off this. How do I
do it? [GP7]
There's a problem with crystal meth usage in Sydney,
all right? And dealing with addiction and substance
abuse, I feel less comfortable with. I don't feel I have
the expertise to deal with that, so I tend to send them
that way for that. [GP11]
An important aspect of this theme is the potential for
burnout in those health care workers – particularly GPs
who are HIV medication prescribers – who are respondingBMC Family Practice 2008, 9:45 http://www.biomedcentral.com/1471-2296/9/45
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to problematic levels of crystal meth use on top of a grow-
ing range of other contextual stressors:
I think it's nasty at the moment, and I think it's nastier
for the health worker too. Especially with crystal meth
... people are nasty, they're horrible and aggressive.
And you become it too, I think. Because that's the only
way you can, because you've got to make very strong
borders, boundaries for them to not cross. And people
become more unreliable. They're narkier, they have
nasty withdrawals. And I think it's a big issue. And I
think it's also a very big issue with a lot of, like people
working in HIV where there may be... A lot of people
are saying there's no evidence, but there's a lot of anec-
dotal talk ... And that a lot of people are going to burn
out. And as you know there are fewer and fewer doc-
tors wanting to do it because they've been told that it's
really hard to do HIV. It's not that hard, it just takes a
lot of effort and will. And I think similarly with the
mental health services. And you've got HIV and you've
got depression, it will wear people out. And then
you've got drugs that make people nasty and horrible,
and weird and inconsolable. Then, it can wear a lot of
people out. [GP9]
Discussion
There are a number of limitations to this study which
must be acknowledged. Firstly, the number of GP inter-
views conducted for the study is small. However, in keep-
ing with the principles of qualitative epistemology,
examining a small amount of qualitative data is a legiti-
mate research tool, particularly if the objective of the anal-
ysis is – as in this case – to understand particular and
contextual experiences rather than to make a claim to rep-
resentativeness and generalisability [15,16]. In addition,
although only sixteen interviews were conducted for this
stage of the study, this sample can be seen to represent a
large proportion of the general practice workforce cur-
rently providing care to gay men and HIV positive men in
the three cities included in the study. For example, the
eleven Sydney-based GPs interviewed represent more
than one third of the total number of s100 HIV prescriber
GPs working in the inner suburbs of Sydney. Secondly,
although the issue of crystal meth use was not raised as an
urgent problem by the GPs based in the other two sites –
one a smaller Australian city, the other a rural-coastal city
– this does not mean that crystal meth use or drug and
alcohol use more broadly is not a problem at all in those
locations. On the contrary, study data not reported here
suggests that drug and alcohol use is a significant issue for
many of the gay men and HIV positive men living in those
cities.
Another important limitation to consider is that, in this
study, the GPs often spoke about the two populations of
gay men and HIV positive men as almost interchangeable.
Sometimes a section of transcript that began with an
observation on gay men would slip into a commentary on
HIV – and vice versa – with little, if any, acknowledge-
ment on the part of the GP that this was occurring. This
may be because almost all of the HIV positive men these
GPs treat are also gay, and that a very high proportion of
the gay men they treat are also HIV positive. Each of these
GPs is based in a practice that has adopted these popula-
tions as the focal point of their work, and which has over
many years developed a reputation for expertise and
understanding in the health and social issues that face
those groups of men. The physical location of inner city
Sydney is also important here, as all four practices are
embedded within social and spatial networks associated
with both gay and HIV positive 'community'. The fact that
these GPs had little sense of the differences between these
two groups – at least in terms of how they talked about
issues such as crystal meth use – suggests that forcing an
arbitrary distinction between them may not be useful, if
only in this context.
Nonetheless there are some key implications that can be
identified from the data reported in this paper. The expe-
riences of these GPs suggests that health practitioners may
benefit from broadening their understandings of how to
anticipate and respond to problematic levels of crystal
meth use in their patients. This is likely to increase the
capacity of GPs and others health practitioners – particu-
larly those working in gay men's health and HIV health
promotion – to intervene at an early stage in order to mit-
igate the impact of crystal meth use on co-morbid mental
illness and other health issues [7]. These GPs articulated a
complex, multi-factorial model of the relationships
between drug use, depression, sexuality and HIV in their
patients. Thus, it is important for health practitioners to
address each of these aspects in turn, rather than prioritis-
ing one as more urgent than another. Of course, there are
some exceptions, such as the fact that the diagnosis and
treatment of depression must usually wait until problem-
atic levels of crystal meth use have been addressed.
Equally, if drug use is affecting compliance with HIV med-
ications then it is critical that drug use be firstly addressed
in order to prevent the development of drug resistance. A
'stepped care' approach is likely to be most appropriate,
particularly for managing co-morbid crystal meth use and
depression [19]. Guidelines for the management of gen-
eral practice patients with crystal meth use problems need
to be further developed to address specific issues associ-
ated with gay men and HIV positive men [20].
Another implication relates to an understanding of the
role that drug use plays in the lives of many gay men. Fol-
lowing Worth and Rawstorne, it is important to appreciate
'these phenomena as social relationships that are part ofBMC Family Practice 2008, 9:45 http://www.biomedcentral.com/1471-2296/9/45
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wider community norms and practices' [12]. GPs and
other health practitioners must build trust with their gay
male patients to ensure that patients are willing to disclose
the full nature of their drug use and other potentially stig-
matised practices. Evidence drawn from the quantitative
arm of this study suggests that this group of GPs has a
heightened awareness for detecting depression in gay men
and HIV positive men [17], demonstrated in a high level
of concordance between GP assessments and patient
screening for depression [21]. In a similar sense, there is a
clear need for education programs to train health practi-
tioners – including referral specialists – to better appreci-
ate the issues pertaining to crystal meth use in gay men
and in HIV positive men. In addition to training, however,
health services need to receive higher levels of resourcing
and support to assist the health workforce to cope with
the often difficult behaviour of patients experiencing
problematic levels of crystal meth use. To avoid an ever
increasing burden being placed on primary care and com-
munity services, there needs to be an increased resourcing
of acute care and referral services to improve their availa-
bility, accessibility and expertise in crystal meth issues.
Conclusion
This is the first study of its kind to report on the experi-
ences of GPs who work with gay men and HIV positive
men in Sydney in relation to crystal meth use and associ-
ated depression. Five key themes were identified. Com-
mencing from the belief that crystal meth use is an
increasing problem in a growing number of these men,
these GPs also observed a strong if complex association
between crystal meth use and depression. Patient crystal
meth use is most often experienced by GPs as a series of
challenges in the clinical management of depression, fur-
ther complicated for those men who are HIV positive.
These GPs also expressed serious concerns regarding the
capacity of existing health services to cope with crystal
meth use, including a perceived stigma among some
health practitioners, and a consequent requirement for
GPs to provide open-minded, non-judgemental care.
Finally, particular issues facing the health workforce were
identified including a sense of GPs being unprepared to
cope with problematic levels of crystal meth use in their
patients as well as a more general lack of capacity (and
possible unwillingness) in the HIV and mental health
workforce due to a growing range of contextual stressors.
Despite some study limitations, key implications can be
identified. Further investigation is required in order to
consider whether these findings are reproducible in other
general practice settings. Other issues that would be par-
ticularly useful to explore further include the relationship
between depression, drug use and HIV medication regi-
mens, as well as the characteristics and challenges facing
the HIV general practice workforce in Australia.
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